Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02657928
Title Ribociclib and Letrozole in Treating Patients With Relapsed ER Positive Ovarian, Fallopian Tube, Primary Peritoneal, or Endometrial Cancer
Recruitment Completed
Gender female
Phase Phase II
Variant Requirements No
Sponsors Mayo Clinic
Indications

fallopian tube carcinoma

ovarian carcinoma

peritoneal carcinoma

endometrial cancer

Therapies

Letrozole + Ribociclib

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.